✓
Open
26 Sep 2022
✓
Close
29 Sep 2022
3
Allotment
—
✓
Listing
Mon, Oct 10, 2022
Price Band
₹101 per share
Issue Size
34,99,200 shares (agg. up to ₹35 Cr)
Lot Size
1,200 Shares
Listing Date
Mon, Oct 10, 2022
Latest GMP
₹2
Est. Gain
1.98%
✦ AI Insight
GMP Trend
10-10-2022₹2Est. ₹103+1.98%
09-10-2022₹2Est. ₹103+1.98%
08-10-2022₹2Est. ₹103+1.98%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 1.25x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2022 | 31 Mar 2021 | 31 Mar 2020 |
|---|---|---|---|
| Assets | 13.86 | 11.44 | 6.39 |
| Total Income | 22.37 | 9.78 | 5.01 |
| Profit After Tax | 2.27 | 0.63 | -0.80 |
| NET Worth | 4.80 | -0.47 | -3.00 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Dipna Pharmachem Ltd. | SME | ₹15.21 Cr | ₹38 | 39 | ₹33.40 | -12.11% | ₹5.35 (-0.93%) |
| JFL Life Sciences Ltd. | SME | ₹18.17 Cr | ₹61 | 26.52 | ₹66.50 | +9.02% | ₹10.50 (-4.55%) |
| Jeena Sikho Lifecare Ltd. | SME | ₹55.50 Cr | ₹150 | 16.67 | ₹173.35 | +15.57% | ₹565.65 (-2.15%) |
| Achyut Healthcare Ltd. | SME | ₹3.60 Cr | ₹20 | 54.05 | ₹21.15 | +5.75% | ₹6.77 (-4.92%) |
| Fabino Life Sciences Ltd. | SME | ₹3.24 Cr | ₹36 | 133 | ₹40.35 | +12.08% | ₹20.31 (+4.96%) |
| Supriya Lifescience Ltd. | Mainboard | ₹700.00 Cr | ₹274 | null | ₹390.85 | +42.65% | ₹828.70 (-2.71%) |
| Sigachi Industries Ltd. | Mainboard | ₹125.43 Cr | ₹163 | null | ₹598.50 | +267.18% | ₹25.02 (+1.96%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To Meet Working Capital Requirements | 20.50 |
| 2 | Product registration in the International Markets | 5.14 |
| 3 | General Corporate Purpose | 6.71 |
| 4 | Public Issue Expenses | 3.00 |
About Trident Lifeline IPO
Incorporated in 2014, Trident Lifeline Limited is engaged in the marketing of pharmaceutical products in domestic as well as international market. The company is also engaged in distribution of pharmaceutical products through third-party distribution network. Trident Lifeline Limited offers a wide range of pharmaceutical formulations and products manufactured on contract manufacturing under a loan licence. Trident Lifeline product portfolio consists of 832 products, as on May 31, 2022, including Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steroidal anti-inflammatory drug (NSAIDs). Trident Lifeline core business categories: 1. Ethical marketing of pharmaceutical formulation & products in the International Market through a third-party distribution network and sales force under its brand. 2. Getting the approved formulations manufactured through Contract Manufacturers, Source & Supply of Generic Pharma formulation and medicines in Domestic as well as International Market. The co
Contact Details
Trident Lifeline Ltd. Address2nd Floor, Shop-2004North Extension, Falsawadi Begumpura, Nodh-4/1650Sahara DarwajaSurat, Gujarat, 3950038160276395compliance@tridentlifeline.comVisit Website